Liu Yanling, Xiong Yujiao, Huang Wenxiang, Jia Bei
Key Laboratory of Infectious and Parasitic Diseases in Chongqing, Department of Infectious Diseases, the First Affiliated Hospital of Chongqing Medical University, No, 1 Youyi Road, Yu Zhong District Chongqing 400016, China.
Ann Clin Microbiol Antimicrob. 2014 May 12;13:17. doi: 10.1186/1476-0711-13-17.
We report here a case of recurrent paratyphoid fever A with hepatitis A co-infection in a patient with chronic hepatitis B. A 26-year-old male patient, who was a hepatitis B virus carrier, was co-infected with Salmonella enterica serovar Paratyphi A and hepatitis A virus. The recurrence of the paratyphoid fever may be ascribed to the coexistence of hepatitis B, a course of ceftriaxone plus levofloxacin that was too short and the insensitivity of paratyphoid fever A to levofloxacin. We find that an adequate course and dose of ceftriaxone is a better strategy for treating paratyphoid fever. Furthermore, the co-infection of paratyphoid fever with hepatitis A may stimulate cellular immunity and break immunotolerance. Thus, the administration of the anti-viral agent entecavir may greatly improve the prognosis of this patient with chronic hepatitis B, and the episodes of paratyphoid fever and hepatitis A infection prompt the use of timely antiviral therapy.
我们在此报告一例慢性乙型肝炎患者并发甲型肝炎且复发性甲型副伤寒热的病例。一名26岁男性患者,为乙肝病毒携带者,同时感染了甲型副伤寒沙门氏菌和甲型肝炎病毒。甲型副伤寒热的复发可能归因于乙肝的并存、头孢曲松加左氧氟沙星疗程过短以及甲型副伤寒热对左氧氟沙星不敏感。我们发现,足够疗程和剂量的头孢曲松是治疗甲型副伤寒热的更好策略。此外,甲型副伤寒热与甲型肝炎的合并感染可能刺激细胞免疫并打破免疫耐受。因此,给予抗病毒药物恩替卡韦可能会大大改善该慢性乙型肝炎患者的预后,而甲型副伤寒热和甲型肝炎感染的发作促使及时进行抗病毒治疗。